Analysis
Facts, interpretation and forecasts kept separate, so you can see exactly where the evidence ends. Competing views side by side.
- 720Hz gaming monitors: a sourced buyer's guide (October 2026)A review roundup of 720Hz monitors from published specs, prices and RTINGS measurements. Native 1080p vs 27-inch dual-mode, and who should buy.Updated
- Can aging be treated? Evidence, hype and the regulatory gapIs aging a treatable condition, and is the evidence strong enough? The debate over animal data, weak human trials, unvalidated clocks and FDA rules.Updated
- How fast are AI agents really improving?AI agents' task horizons are doubling every few months on benchmarks, but real-world gains are harder to measure. The evidence, weighed.Updated
- Why AI chip supply is so concentratedWhy a few firms make the chips, memory and tools behind AI, what the evidence shows as of 2026, and competing views on change.Updated
- Does AI help cyber attackers or defenders more?AI now finds and exploits software flaws. Evidence from DARPA's AIxCC, Google's Big Sleep, Anthropic's Mythos and a reported AI-run espionage campaign.Updated
- Do AI-designed drugs work? What the clinical evidence showsAI-designed drug candidates are reaching patients. What trial data show so far, what they don't, and why "AI-designed" is a contested label.Updated
- Has AI discovered new materials? The debate over GNoME and A-LabAI has predicted millions of crystals and robots have tried to make them. Why chemists dispute the claims, and what would count as proof.Updated
- Can AI safety keep pace with AI capabilities?The central debate in AI safety in 2026: are evaluations, interpretability and oversight keeping up with fast-rising capabilities?Updated
- Should games use AI-generated voices? The AI voice NPC debateAI voice characters promise open-ended conversation in games; performers want consent and pay. Fortnite's AI Darth Vader, the SAG-AFTRA deal and NVIDIA ACE.Updated
- Can battery supply chains diversify away from China?China makes most of the world's batteries and refines most battery minerals. The evidence on whether US and EU tariffs, tax rules and plants can change that.Updated
- Are brain implants ready to become medical products?China approved an invasive BCI in 2026 and US firms are preparing pivotal trials. The evidence for and against implanted BCIs being ready for market.Updated
- Why biomanufacturing still fails at scale-upEngineered strains work in flasks and stall at industrial scale. The evidence on capacity, public plants and platform business models as of October 2026.Updated
- Can carbon removal scale credibly? The 2026 debateCarbon removal must grow from 2 million to billions of tonnes. The evidence on growth, measurement, permanence and demand, and three competing views.Updated
- Casual gaming trends in 2026: fewer downloads, deeper spendingThe forces shaping casual and mobile games in 2026: falling downloads, rising acquisition costs, direct-to-consumer sales and tighter rules on monetisation.Updated
- The CLARITY Act debate: industry, banks, consumer groups, regulatorsWhy the CLARITY Act stalled: the competing views of crypto firms, banks, consumer advocates, senators and regulators, set out side by side as of October 2026.Updated
- Is console emulation legal? Emulators, BIOS files and piracyWhat US law says about emulators, BIOS files and circumvention, from Sony v. Connectix to the Yuzu settlement, and what it means for PS5 emulation.Updated
- What's driving crypto in 2026? Flows, leverage, rates and policyWhy bitcoin and ether slumped then rebounded in 2026: the evidence on ETF flows, leverage, Fed policy and Washington, with competing views as of October 2026.Updated
- The DNA synthesis screening policy debateShould synthesis screening be a funding condition, a statutory rule or an industry norm? The evidence and the competing positions as of October 2026.Updated
- Ethereum ETFs compared: fees, issuers and staking (October 2026)A sourced comparison of US spot ether ETFs by sponsor fee, issuer, size and staking, from fund filings and issuer pages. No hands-on testing; not advice.Updated
- How far will the Fed raise rates? The 2026 rate-path debateAfter the September 2026 hike, Fed officials disagree on how many more increases are needed and how fast. The evidence and views, attributed.Updated
- When will fusion power reach the grid? The 2026 debateCompanies and governments target fusion electricity between 2028 and the mid-2030s. The evidence for and against those timelines as of October 2026.Updated
- Gaming soundbars: a sourced buyer's guide (October 2026)A roundup of soundbars for console and PC gaming based on RTINGS lab findings: passthrough, latency, channels and trade-offs. No hands-on testing.Updated
- Who can get gene-editing cures? The access and cost debateGene-editing therapies like Casgevy can cost millions and need specialist centres. The evidence on access, payment models and global reach in 2026.Updated
- Who gets GLP-1 drugs? The 2026 price and coverage debateGLP-1 prices, Medicare's Bridge, negotiated prices, compounding and generics: the evidence on access in 2026 and the competing views on what comes next.Updated
- Lifelong GLP-1s? The debate over long-term useWhat happens when people stop GLP-1 drugs, what is known about muscle, nutrition and rare side effects, and the competing views on long-term use.Updated
- The Hubble tension and evolving dark energy: is cosmology broken?Is the standard model of cosmology cracking? The evidence on the Hubble tension and DESI's evolving dark energy hint, and the competing explanations.Updated
- Are humanoid robots ready for real work? The 2026 debateEvidence on whether humanoid robots and robot foundation models are ready for factories and homes, with competing views on data, demand and safety.Updated
- How safe is in vivo gene editing? The 2026 debateIn vivo CRISPR therapies are nearing approval, but a 2025 trial death and AAV liver deaths raised safety questions. What the evidence shows.Updated
- Signs of life beyond Earth: how strong is the evidence?K2-18 b and the Cheyava Falls rock on Mars produced the strongest claimed hints of life yet. What the data show, what critics say and what would settle it.Updated
- Loot box regulation in 2026: ban, label or leave it to industry?How Brazil, the EU, the UK, the US and PEGI regulate loot boxes and other game mechanics as of October 2026, and the case for and against tighter rules.Updated
- Moon race or science? The fight over NASA's prioritiesThe White House twice proposed cutting NASA science by nearly half while protecting Artemis. Congress pushed back. What is at stake as of October 2026.Updated
- Mental privacy: should neural data get special protection?Speech BCIs can now decode some inner speech, and laws are catching up. The debate over protecting neural data, from UNESCO to Colorado and the MIND Act.Updated
- After the LHC: the debate over the next big colliderShould Europe build the 15 billion franc Future Circular Collider? The evidence on cost, physics case, alternatives and China's CEPC as of October 2026.Updated
- Oil supply and demand outlook 2026: EIA vs IEA vs OPECEIA, the IEA and OPEC disagree sharply on 2026 oil demand after the Hormuz shock. Their forecasts side by side, with what each assumes, as of October 2026.Updated
- Perovskite solar: ready for rooftops, or still a lab record?Perovskite-silicon tandems set efficiency records, but can they last decades outdoors? The evidence on durability and commercial readiness compared.Updated
- Beyond Moore's law: which hardware bets will pay off?The open debates in next-gen computing hardware: incremental scaling vs radical new compute, how fast optics replaces copper, and vendor claims vs evidence.Updated
- How fast must we move to post-quantum cryptography?Q-Day timing, 2029 corporate targets versus 2030-2035 government deadlines, and whether to rush new algorithms: the post-quantum migration debate.Updated
- Has quantum advantage arrived? The 2026 debateQuantum advantage claims from Google, USTC and IBM, why classical computers keep catching up, and what would settle the debate.Updated
- Do reasoning models really reason? The debate over their limitsReasoning models win maths olympiads yet fail some simple tasks, and their written reasoning is not always faithful. The evidence, weighed.Updated
- Room-temperature superconductors: how close, and how to tell?After LK-99 and a retracted Nature paper, how close is room-temperature superconductivity, and what evidence should convince us? Views compared.Updated
- Solar geoengineering research: the debate in 2026Should scientists study reflecting sunlight to cool the planet? What solar geoengineering is, its risks, current research programmes and competing views.Updated
- How close are solid-state batteries?Toyota, BYD, Samsung SDI and QuantumScape promise solid-state batteries by 2027-28. The evidence on whether that is a breakthrough or a niche start.Updated
- Can immunotherapy crack solid tumours? The 2026 debateSolid tumours are the main frontier of cancer immunotherapy. What 2025-2026 trials show, where they fall short, and the competing readings.Updated
- The US mRNA vaccine policy debate, 2025-2026How US mRNA vaccine policy changed in 2025-2026: FDA label limits, BARDA cuts, ACIP reconstitution and the court case, with each side's arguments.Updated